NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Assets (2020 - 2025)

NeuroSense Therapeutics' (NRSN) quarterly Assets came in at $1.0 million in Q4 2025, down 77.53% year-over-year from $4.6 million in Q4 2024, and down 38.95% quarter-over-quarter from $1.7 million in Q2 2025.

Analysis

NeuroSense Therapeutics (NRSN) Assets (2020 - 2025) Analysis & Trends

NeuroSense Therapeutics has disclosed Assets across 6 years of filings, most recently posting $1.0 million for Q4 2025.

  • In Q4 2025, Assets fell 77.53% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (down 77.53% YoY), while the FY2025 annual figure was $1.0 million, down 77.53% from the prior year.
  • Assets came in at $1.0 million for Q4 2025 at NeuroSense Therapeutics, down from $1.7 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $14.4 million in Q1 2022 to a low of $984000.0 in Q3 2024.
  • Average Assets over 5 years is $5.8 million, with a median of $5.3 million recorded in 2023.
  • Year-over-year, Assets soared 1367.39% in 2021 and tumbled 81.73% in 2024.
  • Over 5 years, Assets stood at $11.4 million in 2021, then sank by 32.49% to $7.7 million in 2022, then tumbled by 58.73% to $3.2 million in 2023, then surged by 43.64% to $4.6 million in 2024, then slumped by 77.53% to $1.0 million in 2025.
  • Per Business Quant data, the three most recent Assets figures were $1.0 million in Q4 2025, $1.7 million in Q2 2025, and $4.6 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn 95.64 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn 49.36 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn 27.42 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn 41.73 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn 10.96 Bn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn 10.03 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn 5.56 Bn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn 32.09 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn 5.31 Bn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn - 1.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.03 Mn
Jun 30, 2025 1.68 Mn
Dec 31, 2024 4.58 Mn
Sep 30, 2024 984,000.00
Jun 30, 2024 1.84 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 3.19 Mn
Sep 30, 2023 5.39 Mn
Jun 30, 2023 7.87 Mn
Mar 31, 2023 5.34 Mn
Dec 31, 2022 7.72 Mn
Sep 30, 2022 9.23 Mn
Jun 30, 2022 11.45 Mn
Mar 31, 2022 14.36 Mn
Dec 31, 2021 11.43 Mn
Dec 31, 2020 779,000.00
API Access

NeuroSense Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY